Skip to main content

Arsenal Capital Partners Announces the Promotion of Three to Investment Partner

December 14, 2017

NEW YORK, December 14, 2017 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in middle-market specialty industrials and healthcare companies, announced today the promotion of Gene Gorbach, Roy Seroussi, and Brian Orkin to Investment Partner.

“We are very pleased to recognize these individuals and their contributions to the firm,” said Arsenal’s co-founder and Partner Jeff Kovach. “At the core of Arsenal’s success is a deep and talented team, and we remain committed to the continuous development of our professionals. Gene, Roy, and Brian each play important leadership roles within Arsenal, and we look forward to many more years of successful partnership with them.”  

Mr. Gorbach joined Arsenal in 2008 as a Senior Associate and currently serves on the boards of three healthcare companies: BioIVT, TractManager, and WCG. Mr. Seroussi joined Arsenal in 2008 as an Associate on the specialty industrials team and currently serves on the boards of Cyalume Technologies, Inhance Technologies, Elite Comfort Solutions, and Polymer Solutions Group. Brian Orkin joined Arsenal in 2010 and plays various business development and strategy roles on the specialty industrials team.

###